| Literature DB >> 31118003 |
Abstract
BACKGROUND: Leishmaniasis is a parasitic disease caused by a protozoan of the Leishmania genus, and is considered a neglected tropical disease. It still remains a main public health concern at global level and in Arab world mainly in low-income countries. Therefore, this study was designed to evaluate the Arab world's growing contribution to global leishmaniasis research.Entities:
Keywords: Arab world; Bibliometric; Leishmania; Leishmaniasis; Scopus
Mesh:
Year: 2019 PMID: 31118003 PMCID: PMC6532175 DOI: 10.1186/s12889-019-6969-9
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Publication distribution from worldwide and Arab world in leishmaniasis during 1998–2017
Contribution and impact of the top 10 countries at global level in leishmaniasis research during 1998–2017
| SCR | Country | Number of documents (%) | Number of collaborating countries | International collaborative publications | |
|---|---|---|---|---|---|
| 1st | Brazil | 3865 (22.00) | 83 | 64 | 910 |
| 2nd | USA | 2729 (15.53) | 119 | 100 | 1633 |
| 3rd | India | 2119 (12.06) | 83 | 68 | 558 |
| 4th | UK | 1363 (7.76) | 102 | 81 | 937 |
| 5th | Spain | 1274 (7.25) | 70 | 68 | 546 |
| 6th | Iran | 1272 (7.24) | 52 | 42 | 180 |
| 7th | France | 1055 (6.00) | 80 | 77 | 582 |
| 8th | Germany | 839 (4.78) | 82 | 68 | 522 |
| 9th | Italy | 714 (4.06) | 57 | 57 | 253 |
| 10th | Canada | 588 (3.35) | 75 | 55 | 341 |
SCR Standard competition ranking
Ranking and contribution the Arab countries in leishmaniasis research during 1998–2017
| SCRa | Country | Number of documents (%) | Number of collaborating countries | International collaborative publications | |
|---|---|---|---|---|---|
| 1st | Tunisia | 297 (29.91) | 31 | 38 | 125 |
| 2nd | Sudan | 192 (19.34) | 43 | 42 | 163 |
| 3rd | Saudi Arabia | 131 (13.19) | 20 | 36 | 92 |
| 4th | Morocco | 119 (11.98) | 21 | 24 | 45 |
| 5th | Egypt | 67 (6.75) | 15 | 29 | 55 |
| 6th | Algeria | 61 (6.14) | 14 | 24 | 45 |
| 7th | Iraq | 44 (4.43) | 9 | 6 | 10 |
| 8th | Palestine | 40 (4.03) | 18 | 23 | 40 |
| 9th | Syrian Arab Republic | 37 (3.73) | 11 | 23 | 15 |
| 10th | Lebanon | 33 (3.32) | 12 | 11 | 17 |
| 11th | Yemen | 25 (2.52) | 9 | 10 | 15 |
| 12th | Jordan | 15 (1.51) | 7 | 11 | 11 |
| 13th | Libyan Arab Jamahiriya | 12 (12.1) | 7 | 9 | 10 |
| 13th | Oman | 12 (1.21) | 6 | 3 | 6 |
| 15th | Bahrain | 9 (0.91) | 5 | 5 | 5 |
| 16th | Kuwait | 6 (0.60) | 5 | 4 | 3 |
| 17th | Qatar | 5 (0.50) | 3 | 5 | 5 |
| 18th | United Arab Emirates | 4 (0.40) | 2 | 2 | 2 |
| 19th | Somalia | 1 (0.10) | 1 | 2 | 1 |
SCR Standard competition ranking
a Equal countries have the same ranking number, and then a gap is left in the ranking numbers
Collaboration between Arab countries and non-Arab countries in leishmaniasis research during 1998–2017
| Country | Number of documents | % | Country | Number of documents | % |
|---|---|---|---|---|---|
| France | 132 | 13.29 | Greece | 6 | 0.60 |
| United States | 99 | 9.97 | Nepal | 6 | 0.60 |
| United Kingdom | 88 | 8.86 | Colombia | 5 | 0.50 |
| Germany | 51 | 5.14 | Czech Republic | 5 | 0.50 |
| Belgium | 47 | 4.73 | Japan | 5 | 0.50 |
| Netherlands | 43 | 4.33 | Nigeria | 4 | 0.40 |
| Switzerland | 39 | 3.93 | Turkey | 4 | 0.40 |
| India | 37 | 3.73 | Cuba | 3 | 0.30 |
| Israel | 29 | 2.92 | Russian Federation | 3 | 0.30 |
| Spain | 24 | 2.42 | South Africa | 3 | 0.30 |
| Kenya | 23 | 2.32 | Austria | 2 | 0.20 |
| Brazil | 20 | 2.01 | Ghana | 2 | 0.20 |
| Ethiopia | 17 | 1.71 | Luxembourg | 2 | 0.20 |
| Pakistan | 17 | 1.71 | Malaysia | 2 | 0.20 |
| Italy | 15 | 1.51 | Uzbekistan | 2 | 0.20 |
| Canada | 14 | 1.41 | Venezuela | 2 | 0.20 |
| Sweden | 14 | 1.41 | Albania | 1 | 0.10 |
| Denmark | 13 | 1.31 | Burkina Faso | 1 | 0.10 |
| Uganda | 12 | 1.21 | Congo | 1 | 0.10 |
| Iran | 10 | 1.01 | Croatia | 1 | 0.10 |
| Australia | 9 | 0.91 | Ecuador | 1 | 0.10 |
| Malawi | 9 | 0.91 | Guatemala | 1 | 0.10 |
| Portugal | 9 | 0.91 | Hong Kong | 1 | 0.10 |
| Bangladesh | 7 | 0.70 | Mexico | 1 | 0.10 |
| Peru | 7 | 0.70 | Singapore | 1 | 0.10 |
| China | 6 | 0.60 | Thailand | 1 | 0.10 |
Top 10 journals related to leishmaniasis research at global level during 1998–2017
| SCRa | Journal | Number of documents (%) | IFb |
|---|---|---|---|
| 1st |
| 523 (2.98) | 4.367 |
| 2nd |
| 492 (2.80) | 2.564 |
| 3rd |
| 364 (2.07) | 1.821 |
| 4th |
| 354 (2.01) | 2.509 |
| 5th |
| 321 (1.83) | 2.766 |
| 6th |
| 307 (1.75) | 2.820 |
| 7th |
| 291 (1.66) | 2.422 |
| 8th |
| 286 (1.63) | 2.833 |
| 8th |
| 286 (1.63) | 1.358 |
| 10th |
| 281 (1.60) | 1.744 |
SCR Standard competition ranking; IF, Impact factor
a Equal journals have the same ranking number, and then a gap is left in the ranking numbers
b Impact factors (IF) based on Journal Citation Reports (JCR) 2017 from Clarivate Analytics
Top 10 journals related to leishmaniasis research from Arab world during 1998–2017
| SCR | Journal | Number of documents (%) | IFa |
|---|---|---|---|
| 1st |
| 46 (4.63) | 2.509 |
| 2nd |
| 44 (4.43) | 2.820 |
| 3rd |
| 42 (4.23) | 4.367 |
| 4th |
| 33 (3.32) | 3.163 |
| 5th |
| 32 (3.22) | 2.564 |
| 6th |
| 25 (2.52) | 2.766 |
| 7th |
| 24 (2.42) | NA |
| 8th |
| 20 (2.01) | 1.703 |
| 9th |
| 19 (1.91) | 2.541 |
| 10th |
| 17 (1.71) | 1.055 |
SCR Standard competition ranking; IF, Impact factor; NA, not available
a Impact factors (IF) based on Journal Citation Reports (JCR) 2017 from Clarivate Analytics
b Currently known as: Pathogens and Global Health (2012 - current)
Fig. 2VOSviewer occurrence term map of the global hot topics of leishmaniasis research over the period of 1998–2017 which extracted from titles and abstracts of publications in the Scopus. The size and color a term indicate the frequency and the cluster with which the terms have been appeared respectively. In general, the closer two terms in the map indicating the stronger their relation. Out of 184,935 terms, 1586 terms meet the threshold by using minimum number of occurrence threshold of 50. By default, VOSviewer reducing the terms to the most relevant 60% results in 952 terms which encompass 4 main clusters in four colors: red, green, yellow, and blue
Fig. 3VOSviewer occurrence term map of the Arab world hot topics of leishmaniasis research over the period of 1998–2017 which extracted from titles and abstracts of publications in the Scopus. The size and color a term indicate the frequency and the cluster with which the terms have been appeared respectively. In general, the closer two terms in the map indicating the stronger their relation. Out of 17,479 terms, 531 terms meet the threshold by using minimum number of occurrence threshold of 10. By default, VOSviewer reducing the terms to the most relevant 60% results in 319 terms which encompass 4 main clusters in four colors: red, green, yellow, and blue
Most 10 frequently cited publications on leishmaniasis research at global level during 1998–2017
| SCR | Authors | Title | year of publication | Source title | Cited by |
|---|---|---|---|---|---|
| 1st | Desjeux [ | Leishmaniasis: Current situation and new perspectives | 2004 |
| 1971 |
| 2nd | Alvar et al. [ | Leishmaniasis worldwide and global estimates of its incidence | 2012 |
| 1400 |
| 3rd | Belkaid et al. [ | CD4 + CD25+ regulatory T cells control Leishmania major persistence and immunity | 2002 |
| 1277 |
| 4th | Herwaldt [ | Leishmaniasis | 1999 |
| 1204 |
| 5th | Murray et al. [ | Advances in leishmaniasis | 2005 |
| 1079 |
| 6th | Croft et al. [ | Drug resistance in leishmaniasis | 2006 |
| 977 |
| 7th | Ivens et al. [ | The genome of the kinetoplastid parasite, Leishmania major | 2005 |
| 912 |
| 8th | Darrah et al. [ | Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major | 2007 |
| 880 |
| 9th | Sacks et al. [ | The immunology of susceptibility and resistance to Leishmania major in mice | 2002 |
| 764 |
| 10th | Chappuis et al. [ | Visceral leishmaniasis: What are the needs for diagnosis, treatment and control? | 2007 | Nature Reviews Microbiology | 704 |
SCR Standard competition ranking
Most 10 frequently cited publications on leishmaniasis research from Arab world during 1998–2017
| SCR | Authors | Title | year of publication | Source title | Cited by |
|---|---|---|---|---|---|
| 1st | Reithinger et al. [ | Cutaneous leishmaniasis | 2007 |
| 685 |
| 2nd | Zijlstra et al. [ | Post-kala-azar dermal leishmaniasis | 2003 |
| 282 |
| 3rd | Alrajhi et al. [ | Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major | 2002 |
| 234 |
| 4th | El Tai et al. [ | Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing | 2000 |
| 199 |
| 5th | Bacaër and Guernaoui [ | The epidemic threshold of vector-borne diseases with seasonality: The case of cutaneous leishmaniasis in Chichaoua, Morocco | 2006 |
| 181 |
| 6th | Khalil et al. [ | Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomised, double-blind, BCG-controlled trial in Sudan | 2000 |
| 173 |
| 7th | Arnoult et al. [ | On the evolution of programmed cell death: Apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization | 2002 |
| 165 |
| 8th | Postigo [ | Leishmaniasis in the World Health Organization Eastern Mediterranean Region | 2010 |
| 148 |
| 9th | Pitta et al. [ | IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani | 2009 |
| 146 |
| 10th | Zijlstra et al. [ | Diagnosing visceral leishmaniasis with the recombinant K39 strip test: Experience from the Sudan | 2001 |
| 140 |
SCR Standard competition ranking
Top 10 institutions most productive of research publications on leishmaniasis at global level during 1998–2017
| SCR | Institute | Country | Number of documents (%) |
|---|---|---|---|
| 1st |
| Brazil | 1427 (8.12) |
| 2nd |
| Brazil | 769 (4.38) |
| 3rd |
| Brazil | 562 (3.20) |
| 4th |
| Iran | 503 (2.86) |
| 5th |
| Brazil | 485 (2.76) |
| 6th |
| India | 385 (2.19) |
| 7th |
| India | 371 (2.11) |
| 8th |
| UK | 345 (1.96) |
| 9th |
| Belgium | 328 (1.87) |
| 10th |
| Brazil | 323 (1.84) |
SCR Standard competition ranking
Top 10 institutions most productive of research publications on leishmaniasis from or collaborating with Arab world affiliations during 1998–2017
| SCR a | Institute | Country | Number of documents (%) |
|---|---|---|---|
| 1st |
| Tunisia | 178 (17.93) |
| 2nd |
| Sudan | 147 (14.80) |
| 3rd |
| Sudan | 82 (8.26) |
| 4th |
| Belgium | 40 (4.03) |
| 5th |
| Germany | 38 (3.83) |
| 6th |
| Tunisia | 35 (3.52) |
| 7th |
| Palestine | 31 (3.12) |
| 8th |
| Algeria | 30 (3.02) |
| 8th |
| France | 30 (3.02) |
| 10th |
| Tunisia | 29 (2.92) |
SCR Standard competition ranking
a Equal institutes have the same ranking number, and then a gap is left in the ranking numbers